713-1269

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
713 (USA) · Dr. Kowalski
consented 2014-01-27

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-02 (study day 7.0); relationship: PROBABLE

mild assessed

Mild COUGH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-04-18 (study day 82.0); relationship: REMOTE

moderate assessed

Moderate RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-10 (study day 165.0); relationship: REMOTE

mild assessed

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-10 (study day 165.0); relationship: REMOTE

mild assessed

Mild SHOULDER PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-01 (study day 126.0); relationship: POSSIBLE

moderate assessed

Moderate SHOULDER PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-01 (study day 126.0); relationship: POSSIBLE

Data queries

No data queries.